BUSINESS DEVELOPMENT
TRACK RECORD
We are a proven partner for success having prepared and facilitated high profile M&A and business development transactions, with many of them having been top ranked among the leading European and global deals.
In the following you will find a select list of deal references.
BENCHMARK - U3 PHARMA - DAIICHI SANKYO
The success of a business development process very much depends on the personal credibility, professional quality and scientific as well as commercia. excellence of our transaction partners. In this respect Irina and her team have been crucial to the completion of our acquisition of U3 Pharma.
DICK VAN DUYNE, SENIOR ADVISOR
(former Head of Global Business Development)
DAICHI SANKYO, CO. LTD
BENCHMARK - EUROPEAN BIOTECH FIRM - MITSUBISHI TANABE
Since we have known each other, Irina has been consistently impressive in her ability to build cases, design BD strategies and appropriately implement them. Among the European Biotech community she is one of the few BD consultants with a solid track record of significant achievements. As investors, we never hesitate to invite our portfolio companies to check her out.
GILLES NOBÉCOURT
PARTNER AT EDMOND DE ROTHSCHILD INVESTMENT PARTNERS
BENCHMARK - EUROPEAN BIOTECH FIRM - ALLERGAN
BENCHMARK - EUROPEAN BIOTECH COMPANY - MERCK & CO
Frontière Médicale makes Womed Leaf® available for women in UK and Ireland
December 5th, 2026
Womed partnered Womed Leaf® in Brazil to Bioargo
July 7th, 2025
Kebomed Europe secures license to distribute Womed Leaf®
April 9th, 2025
Womed licensed Womed Leaf® to Saesco Medical
April 9th, 2025
Transaction Advisor to Allecra Therapeutics GmbH
June 24, 2024